Syngene International Ltd.

NSE: SYNGENE | BSE: 539268 | ISIN: INE398R01022 | Industry: Pharmaceuticals
| Slowing Down Stock
415.0000 12.15 (3.02%)
NSE Apr 15, 2026 15:49 PM
Volume: 935.7K
 

415.00
3.02%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 11% YoY to | 335 crore (I-direct estimate: | 320 crore) due to strong performance in development & manufacturing services and sustained growth in dedicated R&D; centres Gross margins improved 204 bps YoY to 76.1% but EBITDA margins declined 99 bps to 33.9% YoY (I-direct estimate: 33%) mainly due to higher employee expenses. EBITDA in value terms grew 7.5% YoY to | 114 crore (I-direct estimate: | 106 crore)...
Syngene International Ltd.'s price crossed above 30Day SMA today
More from Syngene International Ltd.
Recommended